Clinical trial

Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH

NCT02734953

Study summary

ClinicalTrials.gov

Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Nitric Oxide Normalized identity: nitric oxide View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-04-01

PhasePHASE2

Conditions

Pulmonary Arterial Hypertensionverified · MONDO: pulmonary arterial hypertension

Interventions

Nitric OxideDRUG · verified · RxNorm: nitric oxide

Sponsors & collaborators

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)lead sponsor

Mapped research locations

PittsburghPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02734953 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.